9-hydroxyellipticine has been researched along with Carcinoma, Lewis Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakanishi, N; Ohashi, M; Sugikawa, E | 1 |
1 other study(ies) available for 9-hydroxyellipticine and Carcinoma, Lewis Lung
Article | Year |
---|---|
Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Lewis Lung; CDC2-CDC28 Kinases; Cell Death; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Ellipticines; Enzyme Inhibitors; Histones; Humans; Mice; Mice, Inbred Strains; Microsomes; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |